• 1
    Henk J. Head and neck cancer: surgery or radiotherapy? Clin Oncol. 1998; 10: 139-140.
  • 2
    Wennberg J. Dealing with medical practice variation: a proposal for action. Health Affairs. 1988; 7: 6-32.
  • 3
    Robson A. Evidence-based management of hypopharyngeal cancer. Clin Otolaryngol. 2002; 27: 413-420.
  • 4
    Hoffman HT, Karnell LH, Shah J, Ayiyan S. Hypopharyngeal cancer patient care evaluation. Laryngoscope. 1997; 107: 1005-1017.
  • 5
    Morse J. Approaches to qualitative-quantitative methodological triangulation. Nursing Res. 1991; 40: 120-123.
  • 6
    Horwitz RI, Viscoli CM, Clemens JD, Sadock RT. Developing improved observational methods for evaluating therapeutic effectiveness. Am J Med. 1990; 89: 630-638.
  • 7
    Clayman GL, Weber RS, Guillamondegi O, Byers RM. Laryngeal preservation for advanced laryngeal and hypopharyngeal cancers. Arch Otolaryngol Head Neck Surg. 1995; 121: 219-223.
  • 8
    Pytynia K, Grant J, Etzel C, et al. Matched analysis of survival in patients squamous cell carcinoma of the head and neck diagnosed before and after 40 years of age. Arch Otolaryngol Head Neck Surg. 2004; 130: 869-873.
  • 9
    Groome PA, O'Sullivan B, Irish JC, et al. Glottic cancer in Ontario, Canada and the SEER areas of the United States: do different management philosophies produce different outcome profiles? J Clin Epidemiol. 2001; 54: 301-315.
  • 10
    Groome P, O'Sullivan B, Irish J, et al. Management and outcome differences in supraglottic cancer between Ontario Canada and the SEER areas of the United States. J Clin Oncol. 2002; 21: 496-505.
  • 11
    Newhouse JP, McClellan M. Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health. 1998; 19: 17-34.
  • 12
    Groome P, Schulze K, Keller S, et al. Explaining socioeconomic status effects in laryngeal cancer. Clin Oncol. 2006; 18: 283-292.
  • 13
    Fritz A, Ries L, eds. The SEER Program Code Manual. 3rd ed. Cancer Statistics Branch, Division of Cancer Control and Population Sciences, US Department of Health and Human Services; 1998.
  • 14
    TNM Classification of Malignant Tumours. 6th ed. New York, NY: John Wiley & Sons; 2002.
  • 15
    Piccirillo JF, Tierney R, Costas I, et al. Prognostic importance of comorbidity in a hospital based cancer registry. JAMA. 2004; 291: 2441-2447.
  • 16
    Deleyiannis FW, Thomas DB, Vaughan TL, Davis S. Alcoholism: independent predictor of survival in patients with head and neck cancer. J Natl Cancer Inst. 1996; 88: 542-549.
  • 17
    Kaplan MH, Feinstein AR. The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis. 1974; 27: 387-404.
  • 18
    Zubrod CG, Scheiderman MA, Frei E. Appraisal methods for the study of chemotherapy in man. J Chronic Dis. 1960; 11: 7-33.
  • 19
    Zhang-Salomons J, Sloan M, Mackillop WS. Geographic variations in cancer survival in Ontario. Clin Invest Med. 1998; 21: S94.
  • 20
    Kraus DH, Zelefsky MJ, Brock HA, Huo J. Combined surgery and radiation therapy for squamous cell carcinoma of the hypopharynx. Otolaryngol Head Neck Surg. 1997; 116: 637-641.
  • 21
    Spector J, Sessions D, Emani B, Simpson J, Emani B. Squamous cell carcinoma of the pyriform fossa: a non randomized comparison of therapeutic modalities. Laryngoscope. 1995; 105: 397-406.
  • 22
    Elais MM, Hilgers FJM. Carcinoma of the pyriform sinus. Clin Otolaryngol. 1995; 20: 249-253.
  • 23
    Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A. Larynx preservation in pyriform sinus cancer: preliminary results of a EORTC phase III trial. J Natl Cancer Inst. 1996; 88: 890-898.
  • 24
    Lefebvre J, Chevalier D, Luboinski B, et al. Is laryngeal preservation with induction chemotherapy safe in the treatment of hypopharyngeal SCC? Final results of the phase III EORTC trial. J Clin Oncol. 2004; 14( suppl).
  • 25
    Sewnaik A, Hoorweg JJ, Knegt PP, Wieringa MH, van der Beek JM, Kerrebijn JD. Treatment of hypopharyngeal carcinoma: analysis of nationwide study in the Netherlands over a 10-year period. Clin Otolaryngol. 2005; 30: 52-57.
  • 26
    Kramer S, Gelber R, Marcial V, et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of RTOG 73-03. Head Neck Surg. 1987; 9: 19-27.
  • 27
    Robertson A, Soutar D, Paul J, et al. Early closure of a randomized trial: surgery and postoperative radiotherapy vs radiotherapy in the management of intra-oral tumors. Clin Oncol. 1998; 10: 155-160.
  • 28
    Barbera L, Groome PA, Mackillop W, et al. The role of computed tomography in the T classification of laryngeal carcinoma. Cancer. 2001; 91: 394-407.
  • 29
    Hall S, Schulze K, Groome P, et al. Using cancer registry data for survival studies: the example of the Ontario Cancer Registry. J Clin Epidemiol. 2006; 58: 67-76.